30 March 2019 The US Food and Drug Administration (FDA) recently released a statement announcing amendments to the Mammography Quality Standards Act (MQSA). The “lay person letter” that patients receive with information about their mammogram results, and aspects of mammography facility quality measures, are part of the MQSA.  As noted in the FDA statement, proposed […]

13 March 2019 A recent news article has called attention to an ongoing clinical trial, which is evaluating whether certain patients can avoid surgery for breast cancer. The article has raised many questions, so with the help of the trial principal investigator, surgical oncologist Dr. Henry Kuerer from M.D. Anderson, here is some clarification. The […]

11 March 2019 A study recently published in JAMA Oncology adds to the growing body of literature noting the advantages of digital breast tomosynthesis (DBT), also known as 3D mammography, compared to the more widely available digital (2D) mammography (DM). While mammography is still considered the “gold standard” for breast cancer screening, there are some limitations. […]

26 February 2019 The US Food and Drug Administration (FDA) has issued a safety communication regarding the use of breast thermography as a sole means of breast cancer screening or diagnosis. Thermography has been around for many years, and as seen by the FDA communication, has been the subject of multiple warning letters. Thermography works […]

19 February 2019  A study recently published in Cancer assessed primary care physician (PCP) knowledge about breast cancer treatment decisions, and their comfort level with having treatment option discussions with their patients.  PCPs were identified by their patients as part of a previous study. 61% of the 852 eligible PCPs responded to the survey request. […]

12 February 2019 The American Society of Breast Surgeons has issued updated genetic testing guidelines for patients who have been diagnosed with breast cancer. The new guidelines recommend that genetic testing to include BRCA 1/2 and PALB2 mutations (and other genes as appropriate based on clinical scenario and family history) be made available to all newly […]

11 February 2019 Half a million breast cancer deaths averted! That’s certainly a headline that will get attention. A study just published in Cancer concluded that approximately 500 million deaths from breast cancer among women in the United States (US) have been averted over the past 30 years due to screening mammography and improved therapy. […]